A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
E. Fadlyana, Kusnandi Rusmil, Rodman Tarigan, A. R. Rahmadi +16 more

